Adrenoleukodystrophy
Overview and clinical definition are open. Full Step 1 details unlock with a plan.
For the why behind the fact
Use this page to connect what you are memorizing.
Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.
Overview
Plain-Language Overview
Adrenoleukodystrophy (ALD) is an inherited condition in which a faulty transport protein causes very long-chain fatty acids to build up. Boys and men may develop adrenal hormone deficiency, progressive stiffness and weakness of the legs, or an inflammatory brain disease that affects learning, behavior, vision and movement. These problems can occur separately and at different ages. Women with an ABCD1 variant can also develop substantial leg, bladder and bowel symptoms in adulthood. Regular surveillance matters even before symptoms, because adrenal failure and early cerebral disease need prompt treatment.
Clinical Definition
X-linked adrenoleukodystrophy (X-ALD) results from pathogenic ABCD1 variants that impair ALDP-mediated peroxisomal transport of very long-chain fatty acids (VLCFAs) and their beta-oxidation. Distinguish cerebral ALD (CALD) with inflammatory white-matter demyelination, adrenomyeloneuropathy (AMN) with chronic spinal long-tract axonopathy/peripheral neuropathy, and primary adrenal insufficiency. These manifestations may occur independently or overlap. Adult women commonly develop myelopathy, while cerebral disease and adrenal failure are very rare in women. The variant and plasma VLCFA level do not reliably predict phenotype or severity.